Shareholder Lock in Ends: Lenskart, NSDL and 8 Others Release Over ₹30,000 Crore of Shares

From February 2 to February 6, 2026, lock‑in restrictions lift for ten listed firms, making shares totalling over ₹30,000 crore eligible for trade. The release does not imply immediate selling; it simply removes the holding restriction. 

Shareholder Lock in Expiries Release Over ₹30,000 Crore This Week 

Orkla India will free 34,00,000 shares (2% of equity) on February 2, valued at ₹197 crore and trading 20.6% below its issue price of ₹730.  

Studds Accessories to release 12,00,000 shares (3%) on February 3, worth ₹58.8 crore and 16.2% below the issue price of ₹585.  

Akums Drugs & Pharma to unlock 31.5 million shares (20%) on February 3, valued at ₹1,400.6 crore and 34.5% below its IPO price of ₹679.  

Lenskart Solutions to free 40.7 million shares (2%) on February 4, worth ₹1,781 crore, with the stock up 8.9% from the issue price of ₹402.  

Aditya Infotech to release 74.4 million shares (63%) on February 4, valued at ₹10,359.8 crore. 

NSDL will see 149.2 million shares (75%) become tradable on February 5, worth ₹14,374 crore and trading 20.4% above its issue price of ₹800.  

Sri Lotus Developers frees 79.3 million shares (16%) on February 6, valued at ₹1,191 crore; the share closed at ₹150.26, marginally above the issue price of ₹150.  

M&B Engineering to release 1.6 million shares (3%) on February 6, worth ₹49.25 crore and 20% below its issue price of ₹385.  

Laxmi India Finance to unlock 25.1 million shares (48%) on February 6, valued at ₹227 crore and 42.7% below its IPO price of ₹150.  

Dr Agarwal’s Health Care to free 36.4 million shares (12%) on February 6, worth ₹535.38 crore and up 10.9% from its issue price of ₹402. 

Read More: SEBI Simplifies Legacy Share Claims: Direct Demat Now Allowed Without Letter of Confirmation! 

Overall Impact on Market Liquidity 

The combined release of over ₹30,000 crore adds significant supply potential to the market, particularly for mid‑cap and small‑cap stocks such as Akums Drugs, Aditya Infotech and M&B Engineering. While some securities trade below issue prices, others like NSDL and Lenskart show price appreciation. 

Conclusion 

This week’s lock‑in expiries free up a substantial volume of shares across ten companies, increasing the pool of tradable equity without guaranteeing immediate sales. Market participants now have the option to trade these shares, which may influence short‑term liquidity dynamics. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.